stockrowBeta Bionics, Inc. (BBNX) vs Pacific Biosciences of California, Inc. (PACB)
- Beta Bionics, Inc. BBNX 14.90 −3.81%
- Pacific Biosciences of California, Inc. PACB 2.30 −5.35%
Beta Bionics, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $842.1M against $755.3M — 1.1× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 43.7% against 4.41%. Beta Bionics, Inc. has the higher net margin (−65.3% vs −81.3%) and the lower return on invested capital (−35.9% vs 0.00%). Across the 15 metrics below, Beta Bionics, Inc. leads on 8 and Pacific Biosciences of California, Inc. on 7.
Valuation
Profitability
| Metric | BBNX | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.63% | 34.40% | 57.76% |
| Operating margin | (72.75%) | (81.27%) | (15.07%) |
| Net margin | (65.31%) | (81.31%) | (14.45%) |
| Free cash flow margin | (269.28%) | (84.85%) | (3.88%) |
| Return on equity | (23.88%) | 1,037.83% | (10.35%) |
| Return on assets | (21.48%) | (17.22%) | (17.26%) |
| Return on invested capital | (35.92%) | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack